|
|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Glufosfamide Administered
Using a 1-Hour Infusion Given as First-Line Treatment for Advanced
Pancreatic Cancer. A Phase II Trial of the EORTC-New Drug Development
Group
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Newswire | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |